PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/3/2014

PHARMANIAGA BERHAD

Financial Year End

31/12/2014
Quarter1
Quarterly report for the financial period ended31/03/2014
The figureshave not been audited

Attachments

KLSE 0314.pdf
279 KB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2014

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/03/2014
31/03/2013
31/03/2014
31/03/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
468,672
500,339
468,672
500,339
2Profit/(loss) before tax
38,159
36,924
38,159
36,924
3Profit/(loss) for the period
26,646
25,153
26,646
25,153
4Profit/(loss) attributable to ordinary equity holders of the parent
26,217
24,771
26,217
24,771
5Basic earnings/(loss) per share (Subunit)
10.13
9.57
10.13
9.57
6Proposed/Declared dividend per share (Subunit)
4.00
3.41
4.00
3.41


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.9900
1.8800

Remarks :
The weighted average number of ordinary shares in issue for the purpose of the computation of the earnings per share had been adjusted retrospectively to reflect the Company's share split and bonus issue which were completed on 5 June 2013.
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced14 May 2014  
CategoryFinancial Results
Reference NoPB-140418-63144